Can I Take Lion's Mane with Vardenafil (Levitra/Staxyn)?

At a glance
- Drug / vardenafil (Levitra, Staxyn) is a PDE5 inhibitor FDA-approved for erectile dysfunction
- Supplement / lion's mane (Hericium erinaceus) is used for cognition, nerve support, and general wellness
- Interaction risk level / low to theoretical based on current evidence
- Primary concern / mild antiplatelet effect from lion's mane plus vardenafil's own mild antiplatelet activity
- Secondary concern / unconfirmed possibility that lion's mane affects the enzyme (CYP3A4) that clears vardenafil
- Reasonable dose separation / 2 to 3 hours between lion's mane and vardenafil, as a precaution rather than a proven requirement
- Monitoring / watch for prolonged headache, lightheadedness, or unusual bruising
- Published human interaction data / none identified in the literature reviewed for this article
- Who should get individualized advice first / men on anticoagulants or antiplatelets, strong CYP3A4 inhibitors, or with liver disease
How Vardenafil Works and Why Interactions Matter
Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor that blocks the breakdown of cyclic guanosine monophosphate (cGMP) in penile smooth muscle, increasing blood flow during sexual arousal. It is FDA-approved for erectile dysfunction and is one of several PDE5 inhibitors marketed in the United States [1].
Metabolism Through CYP3A4
Vardenafil is metabolized primarily by cytochrome P450 3A4 (CYP3A4), with a smaller contribution from CYP2C9 [1][2]. Substances that inhibit or induce CYP3A4 can raise or lower vardenafil blood levels. The prescribing label describes a large increase in vardenafil exposure when it is combined with strong CYP3A4 inhibitors such as ketoconazole, which is why the label caps the dose at 2.5 mg when a strong CYP3A4 inhibitor is used concurrently [1][2]. This is the pathway clinicians think about whenever a patient adds a new supplement to a vardenafil regimen; the exact percentage change from any given inhibitor should be checked against the current label rather than assumed.
Hemodynamic Sensitivity
PDE5 inhibitors modestly lower blood pressure on average [3]. That drop is usually not clinically meaningful on its own, but combining vardenafil with other vasodilators or with substances that reduce platelet aggregation adds hemodynamic risk on top of it. The label contraindicates nitrates and limits combination with alpha-blockers [1]. Supplements with vascular or antiplatelet effects sit in a gray zone: not contraindicated, but also not formally studied with vardenafil.
What Lion's Mane Does in the Body
Lion's mane (Hericium erinaceus) is an edible medicinal mushroom studied mainly for two compound families: hericenones and erinacines, which appear to stimulate nerve growth factor (NGF) synthesis [4].
Nerve Growth Factor Stimulation
A double-blind, placebo-controlled trial in 30 Japanese adults with mild cognitive impairment found that lion's mane tablets (250 mg, three times daily for 16 weeks) improved cognitive scores compared with placebo [4]. The proposed mechanism is NGF stimulation. NGF signaling does not overlap with the cGMP/PDE5 pathway that vardenafil acts on, so this cognitive benefit of lion's mane has no obvious direct pharmacological connection to vardenafil.
Antiplatelet Activity
An in vitro study found that Hericium erinaceus extract, and specifically the compound hericenone B, inhibited collagen-induced platelet aggregation in a dose-dependent manner [5]. This is the main interaction-relevant finding in the literature. Vardenafil and other PDE5 inhibitors also have a mild antiplatelet effect through the cGMP-PKG pathway [3]. Combining two agents that both push platelet function in the same direction, even weakly, adds up rather than cancels out.
CYP3A4: A Genuine Evidence Gap
There is no human or animal pharmacokinetic study of lion's mane's effect on CYP3A4 specifically. A separate study has reported that extract from a different mushroom species, Pleurotus eryngii, modulated cutaneous CYP enzymes when applied topically for a skin-photoaging model. That result shows fungal compounds can, in principle, interact with CYP enzymes, but it does not establish anything about Hericium erinaceus, oral dosing, or vardenafil clearance. Treat the CYP3A4 concern as a plausible hypothesis extrapolated from a different organism and a different route of exposure, not as a demonstrated effect of lion's mane.
Pharmacokinetic vs. Pharmacodynamic: Two Types of Interaction Risk
The Pharmacokinetic Question
If lion's mane inhibited CYP3A4, vardenafil clearance would slow and its effects would last longer. Vardenafil's elimination half-life is roughly 4 to 5 hours in healthy men and appears longer in men over 65 [1]. Whether lion's mane has any measurable effect on this pathway in humans is unknown; there is no direct evidence either way.
The Pharmacodynamic Question
This is the mechanism with actual supporting data, though the data are preclinical. Lion's mane's antiplatelet effect [5] and vardenafil's own mild antiplatelet effect [3] share a common downstream endpoint: reduced platelet aggregation. For most healthy men not taking anticoagulants, this additive effect is likely small. For men on warfarin, apixaban, clopidogrel, or dual antiplatelet therapy, even a small incremental antiplatelet push deserves attention, because those patients are already closer to a bleeding threshold.
Pharmacologist Adriane Fugh-Berman, who has written on herb-drug interactions, has argued in the medical literature that the absence of a documented interaction should not be mistaken for evidence of safety, particularly for supplements that affect platelet function alongside a vasoactive drug [7]. That general caution fits this specific pairing: an untested combination of two mild antiplatelet agents is a reasonable thing to flag, even without a case report to point to.
Evidence-Status Assessment: Lion's Mane and Vardenafil
The table below distinguishes established findings from plausible mechanisms of action, and identifies points that healthcare providers should verify before recommending vardenafil with this agent to a patient.
| Claim or mechanism | Evidence status | What supports it | What still needs verification |
|---|---|---|---|
| Vardenafil is cleared mainly through CYP3A4, and strong CYP3A4 inhibitors raise its blood levels substantially | Established (drug labeling) | FDA prescribing information [1][2] | Exact percentage change with any specific inhibitor should be checked against the current label revision |
| Lion's mane stimulates NGF and modestly improved cognitive scores in one small trial | Established in that trial population | Randomized placebo-controlled trial, 30 adults with mild cognitive impairment [4] | No data in men taking PDE5 inhibitors or with erectile dysfunction as the outcome |
| Lion's mane extract (hericenone B) inhibits platelet aggregation | Established in vitro | Laboratory platelet-aggregation study [5] | No human bleeding-time, platelet-function, or dose-response data |
| Vardenafil has a mild antiplatelet effect of its own | Established as a class effect of PDE5 inhibitors | Pharmacology review [3] | Not specific to the vardenafil-lion's mane combination |
| Combining lion's mane and vardenafil produces an additive antiplatelet effect in humans | Pharmacologically plausible, not directly tested | Reasoned from the two rows above | No published case report, cohort study, or trial of the combination |
| Lion's mane meaningfully affects CYP3A4 and alters vardenafil blood levels | Not established for this species or route | Indirect signal from a different mushroom species studied topically, not orally | A human pharmacokinetic study of lion's mane with any CYP3A4 substrate does not appear to exist |
| Direct human interaction data for lion's mane plus any PDE5 inhibitor | Not established | No randomized trial, cohort study, or case series identified in the sources reviewed for this article | Ask the patient about supplement use and dose, and document it, since the literature cannot answer this yet |
Practical Safety: Dose Separation and Monitoring
Dose-Separation Window
Vardenafil reaches peak blood levels roughly 30 to 120 minutes after dosing, depending on whether it is taken with food [1]. Lion's mane supplements are typically taken once or twice daily with meals. Separating the two by at least 2 to 3 hours is a reasonable precaution so peak absorption windows do not overlap, even though no trial has established that this specific window is necessary. Taking lion's mane with breakfast and vardenafil before planned sexual activity in the evening achieves this naturally for most men.
Monitoring Checklist
During the first two weeks of combined use, it is reasonable to track:
- Blood pressure: check seated blood pressure about an hour after vardenafil on a day you also took lion's mane. A large drop from your baseline warrants a conversation with your prescriber.
- Headache: headache is a commonly reported vardenafil side effect, especially at higher doses [1]. A new or worsening headache pattern after adding lion's mane is worth mentioning to your prescriber.
- Bruising or bleeding: watch for unprovoked bruising, nosebleeds that do not stop quickly, or blood in stool, and report these promptly.
- Dizziness on standing: lightheadedness when standing up can suggest additive blood-vessel effects.
When to Stop and Call Your Prescriber
Stop lion's mane and contact your physician for an erection lasting more than 4 hours (priapism), fainting, chest pain, sudden vision or hearing changes, or any new bleeding. Erectile dysfunction guidance from the American Urological Association calls for clinicians to ask about and document all over-the-counter and herbal product use before starting PDE5 inhibitor therapy [8]; the same disclosure matters for anything added afterward, including lion's mane.
Who Should Get Individualized Advice Before Combining Them
Men on Anticoagulants or Antiplatelets
Warfarin, rivaroxaban, apixaban, clopidogrel, or even daily aspirin already shift the balance toward bleeding risk. A systematic review of herbal medicine interactions with warfarin found that herbal antiplatelet and enzyme-interacting compounds are an under-recognized contributor to bleeding risk in patients on anticoagulant therapy [9]. That review was not specific to lion's mane, but it supports treating any additional antiplatelet supplement as a variable worth discussing with a prescriber or pharmacist rather than adding on your own.
Men Taking Strong CYP3A4 Inhibitors
If you already take ritonavir, itraconazole, clarithromycin, or drink grapefruit juice regularly, your vardenafil dose is likely already reduced per the FDA label [1]. Adding a supplement with an unproven, weak CYP3A4 effect introduces another variable that is hard for a prescriber to dose around with confidence.
Men with Liver Disease
The vardenafil label calls for dose adjustment in moderate hepatic impairment and advises against use in severe hepatic impairment, because liver disease increases vardenafil exposure [1]. The exact magnitude of that increase should be confirmed against the current label rather than quoted from memory. Because lion's mane's effects in liver disease are unstudied, caution favors avoiding the combination without a clinician's input in this group.
What the Evidence Actually Shows: A Gap, Not a Green Light
No randomized trial, cohort study, or case series specifically evaluating lion's mane combined with vardenafil, or with any PDE5 inhibitor, appears in the sources reviewed for this article, including PubMed and the Cochrane Library.
Interpreting Absence of Data
Absence of reported problems is not the same as confirmed safety. It may simply reflect that few researchers have studied this specific pairing. A review of common herbal supplement-drug interactions has noted that many popular supplement categories, including mushroom-derived products, have sparse published interaction data compared with how widely they are used [11]. Sparse data is a reason for modest caution and disclosure to a prescriber, not a reason for alarm.
What the Preclinical Data Suggest
The in vitro antiplatelet finding for Hericium erinaceus [5] is specific to lion's mane and is the strongest basis for caution in patients already on blood thinners. The CYP3A4 signal comes from a different mushroom species and a different route of exposure, so it should be treated as a hypothesis, not a finding. The NGF pathway [4] appears unrelated to PDE5 pharmacology.
Lion's Mane Dosing: What Typical Regimens Look Like
Most commercial lion's mane supplements provide 500 mg to 3,000 mg daily of dried fruiting body or mycelium extract. The cognitive impairment trial used 750 mg daily (250 mg three times per day) of a standardized dry powder [4]. Higher-dose, hericenone-standardized extracts may carry a greater theoretical antiplatelet effect than whole fruiting body powder, though human dose-response data for this specific effect are absent.
Standardized Extracts vs. Whole Fruiting Body
Extracts concentrated for hericenones and erinacines deliver more of the bioactive compounds per milligram than whole fruiting body powder. From a caution standpoint, standardized extracts at 1,000 mg or above sit at the higher end of theoretical concern, and whole fruiting body powder at 500 mg daily sits at the lower end. This is a reasonable ordering based on compound concentration, not a measured difference in clinical risk.
Timing Relative to Vardenafil
Men who use vardenafil on demand, rather than daily, have a simple option: skip lion's mane on days they plan to use vardenafil. For those who prefer not to skip doses, a morning lion's mane dose paired with an evening vardenafil dose keeps peak blood levels of the two substances well apart.
What Your Prescriber or Pharmacist Needs to Know
Bring the following to your next appointment if you are taking or considering lion's mane alongside vardenafil:
- Exact product name and dose of your lion's mane supplement, including whether it is fruiting body, mycelium, or a standardized extract.
- Frequency: daily, or cycled (some users take it 5 days on, 2 days off).
- Other supplements and over-the-counter medications: fish oil, vitamin E, ginkgo, and garlic all have antiplatelet properties and can compound the effect discussed above.
- Current vardenafil dose and frequency: on-demand at 5 mg, 10 mg, or 20 mg, or an off-label daily low-dose regimen.
- Any new symptoms since starting the combination, particularly headache, dizziness, or bruising.
A short medication review can catch a problem before it becomes one.
Frequently asked questions
Can I take lion's mane while on vardenafil (Levitra/Staxyn)?
Does lion's mane interact with vardenafil (Levitra/Staxyn)?
Is lion's mane safe to take with PDE5 inhibitors in general?
Can lion's mane cause low blood pressure when taken with Levitra?
How long should I wait between taking lion's mane and vardenafil?
Does lion's mane affect the CYP3A4 enzyme that metabolizes vardenafil?
Should I stop lion's mane before taking vardenafil?
Can lion's mane cause bleeding when combined with vardenafil?
Does lion's mane help with erectile dysfunction?
What other supplements should I be cautious with alongside vardenafil?
Is lion's mane a blood thinner?
Can I take lion's mane with Staxyn (orally disintegrating vardenafil)?
References
- U.S. Food and Drug Administration. Levitra (vardenafil hydrochloride) prescribing information, as cited in the current approved labeling.
- U.S. Food and Drug Administration. Levitra (vardenafil hydrochloride) prescribing information, an earlier revision cited for cross-checking CYP3A4 dosing guidance; readers should consult the current label directly.
- Schwartz BG, Kloner RA. Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension. Circulation. 2010;122(1):88-95. https://pubmed.ncbi.nlm.nih.gov/20606131/
- Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res. 2009;23(3):367-372. https://pubmed.ncbi.nlm.nih.gov/18844328/
- Mori K, Kikuchi H, Obara Y, et al. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation. Phytomedicine. 2010;17(14):1082-1085. https://pubmed.ncbi.nlm.nih.gov/20637576/
- Choi JH, Kim HG, Jin SW, et al. Topical application of Pleurotus eryngii extracts inhibits ultraviolet B-induced photoaging via CYP enzyme modulation. J Ethnopharmacol. 2017;198:208-216. A different mushroom species and route of exposure than lion's mane; cited only to show fungal CYP modulation is biologically plausible, not that it has been demonstrated for Hericium erinaceus. https://pubmed.ncbi.nlm.nih.gov/28062276/
- Fugh-Berman A. Herb-drug interactions. Lancet. 2000;355(9198):134-138. https://pubmed.ncbi.nlm.nih.gov/10675182/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
- Choi S, Oh DS, Jerng UM. A systematic review of the pharmacokinetic and pharmacodynamic interactions of herbal medicine with warfarin. PLoS One. 2017;12(8):e0182794. https://pubmed.ncbi.nlm.nih.gov/28797065/
- Cochrane Library. Search terms: "Hericium erinaceus" and phosphodiesterase inhibitors. Editors should re-run this search directly before publication to confirm current results. https://www.cochranelibrary.com
- Asher GN, Corbett AH, Hawke RL. Common herbal dietary supplement-drug interactions. Am Fam Physician. 2017;96(2):101-107. https://pubmed.ncbi.nlm.nih.gov/28762712/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Klotz T, Sachse R, Heidrich A, et al. Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study. World J Urol. 2001;19(1):32-39. https://pubmed.ncbi.nlm.nih.gov/11289568/
- Natural Medicines Comprehensive Database, Hericium erinaceus monograph. Editors should confirm the current monograph directly rather than rely on a general homepage link. https://www.nih.gov
